ATE263566T1 - Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom - Google Patents

Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom

Info

Publication number
ATE263566T1
ATE263566T1 AT99961332T AT99961332T ATE263566T1 AT E263566 T1 ATE263566 T1 AT E263566T1 AT 99961332 T AT99961332 T AT 99961332T AT 99961332 T AT99961332 T AT 99961332T AT E263566 T1 ATE263566 T1 AT E263566T1
Authority
AT
Austria
Prior art keywords
multiple myeloma
treatment
bone damage
medical compositions
pharmaceutical compositions
Prior art date
Application number
AT99961332T
Other languages
English (en)
Inventor
Shohei Tanaka
Hironobu Asano
Utane Matsukawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of ATE263566T1 publication Critical patent/ATE263566T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT99961332T 1998-12-25 1999-12-22 Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom ATE263566T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP36869998 1998-12-25
PCT/JP1999/007236 WO2000038694A1 (fr) 1998-12-25 1999-12-22 Compositions de medicaments servant a traiter les lesions osseuses dans le myelome multiple

Publications (1)

Publication Number Publication Date
ATE263566T1 true ATE263566T1 (de) 2004-04-15

Family

ID=18492511

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99961332T ATE263566T1 (de) 1998-12-25 1999-12-22 Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom

Country Status (12)

Country Link
US (2) US6727233B1 (de)
EP (1) EP1147773B1 (de)
JP (1) JP3219402B2 (de)
KR (1) KR100609256B1 (de)
CN (1) CN1151793C (de)
AT (1) ATE263566T1 (de)
AU (1) AU1798700A (de)
CA (1) CA2356294C (de)
DE (1) DE69916326T2 (de)
ES (1) ES2220133T3 (de)
TW (1) TW476649B (de)
WO (1) WO2000038694A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4692283B2 (ja) * 2003-12-12 2011-06-01 アステラス製薬株式会社 悪性黒色腫治療剤
WO2005072746A1 (ja) * 2004-01-30 2005-08-11 Astellas Pharma Inc. P2x受容体阻害剤
WO2005072747A1 (ja) * 2004-02-02 2005-08-11 Ono Pharmaceutical Co., Ltd. 骨吸収抑制剤
US7403028B2 (en) * 2006-06-12 2008-07-22 Cascade Microtech, Inc. Test structure and probe for differential signals
WO2022026950A2 (en) * 2020-07-31 2022-02-03 Bioventures, Llc Cst6, cells expressing cst6 and methods of use
CN115040524A (zh) * 2022-07-27 2022-09-13 深圳市中西医结合医院 4-胆甾烯-3-酮用于治疗多发性骨髓瘤骨病的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4990503A (en) 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives
JPH0699457B2 (ja) * 1988-08-12 1994-12-07 山之内製薬株式会社 ヘテロ環ビスフォスフォン酸誘導体およびその医薬
CA2137665A1 (en) 1992-06-23 1994-01-06 Yasuo Isomura Novel crystal of monohydrate of heterocyclic bis(phosphonic acid) derivative
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
PT998292E (pt) * 1997-07-22 2002-04-29 Merck & Co Inc Metodo para inibicao da reabsorcao ossea

Also Published As

Publication number Publication date
US20040043966A1 (en) 2004-03-04
EP1147773B1 (de) 2004-04-07
US6727233B1 (en) 2004-04-27
AU1798700A (en) 2000-07-31
KR100609256B1 (ko) 2006-08-04
DE69916326T2 (de) 2005-03-17
CN1151793C (zh) 2004-06-02
EP1147773A1 (de) 2001-10-24
US6987100B2 (en) 2006-01-17
ES2220133T3 (es) 2004-12-01
JP3219402B2 (ja) 2001-10-15
WO2000038694A1 (fr) 2000-07-06
TW476649B (en) 2002-02-21
CA2356294C (en) 2007-06-05
CA2356294A1 (en) 2000-07-06
CN1331598A (zh) 2002-01-16
DE69916326D1 (de) 2004-05-13
KR20010092751A (ko) 2001-10-26
EP1147773A4 (de) 2002-07-03

Similar Documents

Publication Publication Date Title
SE9901272D0 (sv) New improved formulation
DE69905488D1 (de) Prostaglandin-konjugate zur behandlung von knochenkrankheiten
EP1275396A3 (de) Verwendung von Angiotensin II Fragmenten und deren Analogen fÜr Gewebewiederherstellung
WO2002074234A3 (en) Method and composition for treatment of skeletal dysplasias
AP9901478A0 (en) Compounds for the treatment of ischemia.
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
ATE471149T1 (de) Verwendung von bisphosphonaten zur behandlung von vaskulärer restenose
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
ATE263566T1 (de) Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom
IL143469A0 (en) Use of bisphosphonates for the prevention and treatment of infectious processes
ATE329619T1 (de) Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden
AU8806798A (en) Diphosphonic acid salts for the treatment of osteoporosis
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
DE69902999T2 (de) Glucocorticoide zur behandlung von glomerulonephitis
DE69030732D1 (de) Antiparasitäre zusammensetzung zur verwendung bei tieren
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose
DE60028682D1 (de) Wachstumhormone Inhibitoren Enthaltende pharmazeutische Zubereitungen oder ihre biologisch aktive Fragmente zur Behandlung von uterinen Myomas
ATE263556T1 (de) Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose
HUP9902191A2 (hu) Az érképződést gátló anyag
DE29903763U1 (de) Cerclage-Band zur Behandlung von Knochenbrüchen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties